AIM: To study expression of tissue factor (TF) in pancreatic cancer and its role in the development of thromboembolism. METHODS: TF expression was studied in eight human pancreatic carcinoma cell lines by Northern blot and indirect immunofluorescence. Expression of alternatively spliced TF (asTF) was assessed by RT-PCR. In addition, TF expression was determined by immunofluorescence in pancreatic tissues of 19 patients with pancreatic adenocarcinoma (PCa), 9 patients with chronic pancreatitis (CP) and 20 normal controls. Plasma samples (30 PCa-patients, 13 CP-patients and 20 controls) were investigated for soluble TF levels and coagulation activation markers [thrombin-antithrombin III complex (TAT), prothrombin fragment 1 + 2 (F1 + 2)]. RESULTS: All pancreatic carcinoma cell lines expressed TF (8/8) and most of them expressed asTF (6/8). TF expression at the protein level did not correlate with the differentiation of the carcinoma cell line. All but two pancreatic cancer tissue samples stained positive for TF (17/19). In all samples of CP weak staining was restricted to pancreatic duct cells, whereas only a few subendothelial cells were positive in 9/20 of normal controls. TF and TAT levels in PCa patients were significantly elevated compared to controls whereas elevated F1 + 2 levels did not reach statistical significance compared to controls. In CP patients TAT and F1 + 2 levels proved to be significantly elevated compared to controls, although TAT elevation was less pronounced than in PCa patients. CONCLUSION: We conclude that in addition to the upregulated expression of TF on the cell membrane, soluble TF might contribute to activation of the coagulation system in pancreatic cancer.
AIM: To study expression of tissue factor (TF) in pancreatic cancer and its role in the development of thromboembolism. METHODS:TF expression was studied in eight humanpancreatic carcinoma cell lines by Northern blot and indirect immunofluorescence. Expression of alternatively spliced TF (asTF) was assessed by RT-PCR. In addition, TF expression was determined by immunofluorescence in pancreatic tissues of 19 patients with pancreatic adenocarcinoma (PCa), 9 patients with chronic pancreatitis (CP) and 20 normal controls. Plasma samples (30 PCa-patients, 13 CP-patients and 20 controls) were investigated for soluble TF levels and coagulation activation markers [thrombin-antithrombin III complex (TAT), prothrombin fragment 1 + 2 (F1 + 2)]. RESULTS: All pancreatic carcinoma cell lines expressed TF (8/8) and most of them expressed asTF (6/8). TF expression at the protein level did not correlate with the differentiation of the carcinoma cell line. All but two pancreatic cancer tissue samples stained positive for TF (17/19). In all samples of CP weak staining was restricted to pancreatic duct cells, whereas only a few subendothelial cells were positive in 9/20 of normal controls. TF and TAT levels in PCa patients were significantly elevated compared to controls whereas elevated F1 + 2 levels did not reach statistical significance compared to controls. In CP patients TAT and F1 + 2 levels proved to be significantly elevated compared to controls, although TAT elevation was less pronounced than in PCa patients. CONCLUSION: We conclude that in addition to the upregulated expression of TF on the cell membrane, soluble TF might contribute to activation of the coagulation system in pancreatic cancer.
Authors: Mattias Belting; Michael I Dorrell; Staffan Sandgren; Edith Aguilar; Jasimuddin Ahamed; Andrea Dorfleutner; Peter Carmeliet; Barbara M Mueller; Martin Friedlander; Wolfram Ruf Journal: Nat Med Date: 2004-04-18 Impact factor: 53.440
Authors: Vladimir Y Bogdanov; Viji Balasubramanian; James Hathcock; Oana Vele; Mark Lieb; Yale Nemerson Journal: Nat Med Date: 2003-03-24 Impact factor: 53.440
Authors: Begüm Kocatürk; Yascha W Van den Berg; Chris Tieken; J Sven D Mieog; Esther M de Kruijf; Charla C Engels; Martijn A van der Ent; Peter J Kuppen; Cornelis J Van de Velde; Wolfram Ruf; Pieter H Reitsma; Susanne Osanto; Gerrit-Jan Liefers; Vladimir Y Bogdanov; Henri H Versteeg Journal: Proc Natl Acad Sci U S A Date: 2013-06-25 Impact factor: 11.205
Authors: Chiara Giannarelli; Matilde Alique; David T Rodriguez; Dong Kwon Yang; Dongtak Jeong; Claudia Calcagno; Randolph Hutter; Antoine Millon; Jason C Kovacic; Thomas Weber; Peter L Faries; Gerald A Soff; Zahi A Fayad; Roger J Hajjar; Valentin Fuster; Juan J Badimon Journal: Circulation Date: 2014-08-12 Impact factor: 29.690
Authors: Haiming Luo; Christopher G England; Shreya Goel; Stephen A Graves; Fanrong Ai; Bai Liu; Charles P Theuer; Hing C Wong; Robert J Nickles; Weibo Cai Journal: Mol Pharm Date: 2017-03-24 Impact factor: 4.939
Authors: Y W van den Berg; L G van den Hengel; H R Myers; O Ayachi; E Jordanova; W Ruf; C A Spek; P H Reitsma; V Y Bogdanov; H H Versteeg Journal: Proc Natl Acad Sci U S A Date: 2009-10-29 Impact factor: 11.205
Authors: Hao Hong; Yin Zhang; Tapas R Nayak; Jonathan W Engle; Hing C Wong; Bai Liu; Todd E Barnhart; Weibo Cai Journal: J Nucl Med Date: 2012-09-17 Impact factor: 10.057